Brazil vs Peru: HIV-positive TB patients on ART (antiretroviral therapy)
Brazil
59.0%
in 2024
Peru
57.0%
in 2024
Brazil rank
136th
Peru rank
137th
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Brazil
- Peru
How they compare
Brazil currently reports 59.0% against 57.0% in Peru, a difference of 2.0%.
The two have swapped places 4 times across 18 shared years of data; in 2003 it was Brazil ahead.
Brazil ranks 136th and Peru ranks 137th of 144 countries.
Brazil has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Brazil | Peru | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 95.4% | 17.7% | 77.7% | Brazil |
| 2010s | 66.9% | 59.8% | 7.1% | Brazil |
| 2020s | 56.0% | 53.8% | 2.2% | Brazil |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Brazil or Peru?
- Brazil, at 59.0% against 57.0% in Peru as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Brazil and Peru?
- 2.0%, with Brazil ahead.
- How many years of comparable data are there for Brazil and Peru?
- 18 years are reported by both, from 2003 to 2024.
- How do Brazil and Peru rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Brazil ranks 136th and Peru ranks 137th of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.